Acquisition history FDS Amplicare is now part of EnlivenHealth, with prior acquisition activity including MarkeTouch Media in 2021 and Omnicell acquiring Amplicare in 2021. This indicates a potential cross-sell of EnlivenHealth and Omnicell product lines to a pharmacy-focused customer base.

Pharmacy focus Business targets independent pharmacies and pharmacy networks, evidenced by partnerships and analytics offerings for Mutual Drug and connections to pharmacy registries. Opportunity to upsell pharmacy workflow optimization, adherence, and data analytics to enhance patient outcomes.

Vaccine registry Recent vaccine registry and querying capabilities launched in 2021 suggest capabilities in immunization data exchange and regulatory reporting. Sales angles include vaccine administration workflow integration and state registry submission enhancements for pharmacies.

Analytics lineage Mutual Drug Analytics and analytics-oriented product launches indicate appetite for data-driven decisions. Potential to propose expanded analytics, data integration, and reporting solutions for independent networks and group purchasing organizations.

Tech and scale Tech stack includes cloud-ready databases and modern tooling (Amazon Aurora, Google Workspace, D3.js) with a lean employee base. This signals a need for scalable, secure, cloud-based solutions and services that fit mid-market pharma software needs.